GRACE ZHOU Ph.D
Grace Zhou Ph.D. is the CEO of Immvira. She is a Distinguished Professor, Shenzhen
International Institute for Biomedical Research, formerly
Research Associate Professor, The University of Chicago. She is the author of numerous
publications and holder of numerous patents related to Immvira goals.
THOMAS E. SHENK Ph.D
Thomas E. Shenk Ph.D is a Distinguished Professor at Princeton University. He served
for many years on the BOD of Merck. He published extensively on the biologic properties
of human herpesviruses and holds numerous patents. He is the recipient of numerous
awards including membership in the National Academy of Sciences US, National Academy of
RICHARD J. WHITLEY M.D
Richard J Whitley MD is a Distinguished Professor of Pediatrics, Microbiology and
Medicine at the University of Alabama at Birmingham. He is considered to be one of the
foremost experts in the role of viruses in human infections and is the recipient on
numerous awards and recgnions. He a member of the BOD of Gilead and chairs numerous
panels at NIH.
RALPH R. WEICHSELBAUM M.D
Ralph R. Weichselbaum MD is a Distinguished Service Professor and Chairman of the
Department of Radiation Oncology at the University of Chicago. He is widely recognized
as a world expert in cancer treatment and is the recipient of numerous awards and
recognition including membership in the National Academy of Medicine. He is the author
of numerous publications and patents related to cancer treatment.
DONGYAO NI M.D
Dr. Dongyao Ni graduated from Shanghai Jiaotong University School of Medicine. He was a
trained oncology and vascular surgeon. He was trained in Princeton University and
University of Chicago for his postdoc training in immunology, and participated in
several clinical research projects in US. As Chief Medical Officer of Immvira, Dr. Ni.
Is leading the preclinical and clinical development of Immvira products.